Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | 100 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine (Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution) | [1] Brimonidine
Brimonidine
💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 2 | 200 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine (Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution) | [1] Brimonidine
Brimonidine
💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 3 | 400 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine (Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution) | [1] Brimonidine
Brimonidine
💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|
| 4 | Brimonidine tartrate | [1] Brimonidine Brimonidine (Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution) | [1] Brimonidine
Brimonidine
💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2] 13 13, 90 💬
|
| 5 | Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System | [1] Brimonidine Brimonidine (Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution) | [1] Brimonidine
Brimonidine
💬
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 💬
|